Struggling Baxter gives hedge fund a seat on its board
Baxter International Inc., the Deerfield-based maker of hospital supplies whose stock has slipped 16 percent in the past year, has agreed to give a board seat to a representative of...
Home > Reviews
All Stories
Life sciences industry deals rack up $275B in first half of year
Life sciences companies racked up deals at a blistering pace in the first half of this year, closing $275 billion worth of mergers and acquisitions, nearly four times as much...
AbbVie latest drugmaker to open research center in Cambridge, Mass.
AbbVie Inc. plans to open a research center in Cambridge, Mass., making it the latest pharmaceutical company to set up shop in one of the nation's premier biotech centers. The...
Drug with jacked up price can only be found at some Walgreens. Why?
A lifesaving drug that became the center of a national furor this week after its manufacturer raised the price by about 5,000 percent can only be found at select Walgreens...
Pressure grows over drugmaker that raised price of infection-fighting drug
U.S. Rep. Jan Schakowsky, a longtime pharmaceutical industry critic, is calling for a congressional inquiry into why a small drug company sharply raised the price of a drug that treats...
Humira: One drug. Nine uses. More on the way?
You might call it the Swiss army knife of pharmaceutical drugs. Since it hit the market in 2002 to treat rheumatoid arthritis, Humira has racked up one governmental approval after...
Shire CFO: We’re being patient in acquiring Baxalta
Irish drugmaker Shire Inc., rebuffed earlier this summer in its efforts to buy Chicago-area drug company Baxalta Inc. for $30 billion, is not giving up. "We continue to be committed...
Industries Americans love and hate
Good chance nobody asked you for your opinion. But the folks at Gallup asked plenty of other people to rate 25 major U.S. business sectors to see which were most...
Illinois gets $3.6M federal grant to fight prescription drug abuse
As prescriptions for pain medications continue to soar in Illinois, state officials want to improve its prescription drug monitoring program so doctors and pharmacists can keep track of how many...
A $90 million payday for Hospira CEO after sale to Pfizer
Michael Ball, former CEO of Lake Forest-based drugmaker Hospira Inc., just got a $90 million booster shot. On Thursday, the same day that pharmaceutical giant Pfizer Inc. completed its acquisition...